https://finance.yahoo.com/news/argus-downgrades-biogen-trial-delays-143701552.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAM1dGRtdm9sZDhoY2FmBGcDZFhWcFpEeHVjejQ1WXpBek1EUXpPQzFsTnprd0xUTTFabUV0WWpabFlpMHpOV0kyTm1KbE1qQm1aamQxZFdsa1BHNXpQa0pKU1VJPQ0KBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMxBHJlZ2lvbgNVUwRzeW1ib2wDQklJQg--?.tsrc=applewf
very interesting. Not sure the additional patients means anything beyond more data. I wouldnt read much into this.
Reactions are mixed depending on the news outlet. Read we did the same for tec so doesnt seem too insane.